Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Operating Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,194 Cr₹1,751 Cr₹912 Cr₹264 Cr₹604 Cr

What is the latest Operating Profit of NATCO PHARMA ?

The latest Operating Profit ratio of NATCO PHARMA is ₹2,194 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,194 Cr
Mar2024₹1,751 Cr
Mar2023₹912 Cr
Mar2022₹264 Cr
Mar2021₹604 Cr

How is Operating Profit of NATCO PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,194 Cr
25.26
Mar2024 ₹1,751 Cr
92.10
Mar2023 ₹912 Cr
246.00
Mar2022 ₹264 Cr
-56.36
Mar2021 ₹604 Cr -

Compare Operating Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,782.6 Cr -2% 5.9% 22.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -3.1% 1.6% 5.6% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -1.5% -3.4% 9.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -4.1% -1.2% 40.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.5% -0.9% 16.8% Stock Analytics
CIPLA ₹100,056.0 Cr -5.7% -7.8% -13.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2%

5.9%

22.6%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses